Figure 2

NCI research funding relative to societal health cost as measured by YLL. Dashed line indicates funding if resources are equitably shared according to burden imposed by YLL, cancers above the line receive more funding relative to YLL than expected whereas cancers below the line receive less. Due to its extremely large %YLL (approx. 30%) and relatively low funding (approx. 10%), lung cancer is excluded from this plot and was not used in these calculations.